Cargando…
Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation
PURPOSE: Intravitreal injection of the VEGF-binding protein aflibercept is widely used to treat various ocular diseases. In vitro, immortalized bovine retinal endothelial cells (iBREC) take up and transport aflibercept through the cell layer in a serum-dependent manner, likely mediated through the n...
Autores principales: | Deissler, Heidrun L., Lang, Gerhard K., Lang, Gabriele E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323079/ https://www.ncbi.nlm.nih.gov/pubmed/30367290 http://dx.doi.org/10.1007/s00417-018-4166-7 |
Ejemplares similares
-
Ranibizumab efficiently blocks migration but not proliferation induced by growth factor combinations including VEGF in retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2013) -
Binding of VEGF-A is sufficient to abrogate the disturbing effects of VEGF-B together with VEGF-A on retinal endothelial cells
por: Deissler, Heidrun L., et al.
Publicado: (2015) -
Actions of bevacizumab and ranibizumab on microvascular retinal endothelial cells: similarities and differences
por: Deissler, Heidrun L, et al.
Publicado: (2012) -
Sitagliptin and the Blood-Retina Barrier: Effects on Retinal Endothelial Cells Manifested Only after Prolonged Exposure
por: Jäckle, Anja, et al.
Publicado: (2020) -
Type of culture medium determines properties of cultivated retinal endothelial cells: induction of substantial phenotypic conversion by standard DMEM
por: Busch, Catharina, et al.
Publicado: (2021)